Q1:
The project follows a standardized directory structure to ensure both reproducibility and long-term maintainability. By separating concerns—keeping raw data in data/, exploratory analysis in notebooks/, and core logic in src/—the project remains organized as it scales. Using a src/ package with setup.py allows for clean versioning and prevents path-related errors when importing modules. Additionally, including an environment.yml ensures that the exact computational environment can be reconstructed by other researchers, fulfilling the core requirements of reproducible research.
Q2:
I chose the MIT License for the code and project framework.
Reasoning: As a researcher, my goal is to maximize the impact and accessibility of my tools. The MIT License is a permissive license that allows others to freely use, modify, and distribute the code, even for commercial purposes, provided that the original copyright notice is included. This ensures that I receive credit (attribution) while removing barriers for collaboration within the scientific community.
Q3:
I evaluated the UK Biobank dataset based on FAIR principles:

Findable: Yes. It uses persistent identifiers and is indexed in major global research databases with rich metadata.

Accessible: Partially. While metadata is public, the actual genetic and imaging data require a formal application and access fee. This "controlled access" is standard for sensitive human health data to maintain participant privacy.

Interoperable: Yes. The dataset utilizes standardized formats (e.g., DICOM for neuroimaging, BGEN for genomics) and follows international coding systems like ICD-10 for clinical outcomes.

Reusable: Yes. It provides extensive documentation, clear data usage agreements, and a proven track record of supporting thousands of peer-reviewed publications.
